Insulin Secretion in Diabetes Before and After Glycemic Control
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The objective of this project is to understand defects in insulin secretion that contribute
to abnormal glucose metabolism in patients with diabetes. In particular the effects of
signals released from the intestine to stimulate insulin secretion will be tested. Patients
with type 2 diabetes will have insulin secretion in response to glucose and intestinal
factors before and after insulin treatment to lower their blood glucose. It is expected that
the results of this work will provide valuable information for treating diabetic people.
Phase:
N/A
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development